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Sequence Analysis of Ribosomal Protein Gene, L14 in Human Colorectal Carcinoma 
Cell Line. 
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Structural information of ribosomal proteins (RPs) has increased the understanding of the 
structure, function and evolution of the ribosome. RPL 14 is one of the most conserved 
ribosomal proteins and have a major role in the ribonucleoprotein complex. Previous 
investigations have revealed that RPs gene expression in colorectal carcinomas (CRC) 
differs from that was found in normal colorectal cells; some are upregulated and some are 
down regulated. It has been inferred that the unregulated expression of RPs are associated 
with the differentiation, progression or metastasis of CRC. This project analyses one of the 
RP genes, RPL 14 which is taken from colorectal cancer cells. Analysis shown that RPL 14 
gene extracted has not undergo any mutation as the nucleotide sequence reflects 99% identity 
from the sequence in Genbank. Besides that, translation result of RPL 14 illustrated that RPL 
14 gene encodes a few biologically important sites such as phosphorylations sites for many 
protein kinases, myristoylation site, and leucine zipper pattern which makes RPL 14 one of 
the common housekeeping genes in human. 
 
Keywords: Ribosomal proteins, RPL 14, colorectal cancer, housekeeping genes. 
 
ABSTRAK 
Maklumat struktur tentang protein ribosom telah memberikan kefahaman yang lebih 
mendalam berkenaan tentang struktur, fungsi dan evolusi organel ribosom. RPL 14 adalah 
salah satu protein ribosom yang kekal dan terlibat secara signifikan dalam penghasilan 
komplex ribonucleoprotein. Kajian terdahulu telah berjaya mengupas bahawa ada 
perbezaan di dalam tahap pengeksperesan gen protein ribosom di dalam kanser kolorektal. 
Oleh sebab ini, inferens telah dicadangkan bahawa ketidakstabilan ekspresi gen protein 
ribosom ada perkaitan dengan pembezaan, perkembangan atau metastasis kanser kolorektal 
itu sendiri. Projek ini telah menganalisa salah satu gen protein ribosom iaitu RPL 14 yang 
diekstrak dari sel kanser kolorektal. Analisa menunjukkan bahawa RPL 14 tidak mengalami 
sebarang mutasi di mana urutan nukleotida menunjukkan 99% identiti. Selain itu, keputusan 
translasi RPL 14 menggambarkan gen RPL 14 mengekod untuk beberapa lokasi proses 
biologi yang penting seperti tapak pengfosforilan untuk protein kinase, tapak mirisotoylasi, 
dan corak zip leusin di mana sekaligus membuktikan RPL 14 sebagai salah satu gen penjaga 
dalam manusia. 





Ribosomes, which serve to synthesize proteins are made of several elements which are 
ribosomal RNAs (rRNAs), ribosomal proteins (RPs) and accessory factors called protein 
associated with ribosomes (PAR). Besides this function to combine with rRNA in protein 
biosynthesis, RPs also fill various roles that are called extraribosomal functions. These 
functions though are vast, they are still unclear. However, it is widely interpreted that some 
of these functions include DNA replication, transcription and repair, RNA splicing and 
modification, cell growth and proliferation, regulation of apoptosis and development, and 
cellular transformation (Mao-De & Jing, 2007).  
It is generally accepted that the rRNA is the principal catalytic component of the 
ribonucleoprotein complex. Its activity depends upon a precise three-dimensional 
organization, ribosomal proteins appear to hold on to major role of promoting the folding, 
and consequently, stabilizes the complex RNA tertiary structure. Thus, this common role of 
proteins exhibits how specific amino acids mutation can greatly affect the ribosome’s 
functions. Protein mutation that disrupt their interaction with RNA can modulate the local 
RNA structure and hence its activity (Davies, White & Ramakrishnan, 1995). Recent studies 
confirmed that RP gene mutations or disturbance in expression levels were found in many 
inherited genetic diseases such as Diamond-Blackfan anaemia syndrome, Turner syndrome, 
and Noonan syndrome. Consequently, similar results appeared to be in carcinoma of breast, 
oesophagus, liver and also colon. Jass (2006) also reported that the development and 
progression of colorectal cancer (CRC) does involves complex process of multiple genetic 
changes whereby a series of genetic alterations happens which includes mutations that 
activate oncogenes and inactivate tumour suppressor genes. To add, the expression of RPs 




A preliminary study done by Sim et al. (2006) found 33 RPs genes to be differentially 
expressed in CRC cases of Malaysia. Consequently, when these 33 RPs were coordinated 
with the Cancer Gene Expression Database (CGEP), 22 of them were confirmed to be 
persistently expressed differentially in CRC. Attention should be given to RPL 14 as it has 
been listed to be one of the 22 RP genes that are differentially expressed whereby its level 
of expression was seen to be up-regulated in CRC compared to the normal colorectal sample. 
Therefore, this project aimed to analyse the nucleotide sequence of RPL 14 gene in CRC as 
this gene might be a potential diagnostic biomarker of this disease. The two main objectives 
of this study were: 
(a) To analyse the sequence of RPL 14 gene in CRC cell line, HCT 116 and thus compare 
it with RPL 14 homo sapiens sequence that are readily available in Genbank 
database. 
(b) To predict the amino acids compositions as well as the motifs that RPL 14 protein 
encodes for, so that the importance of RPL 14 protein can be deduced. 
RT-PCR method was performed on RNAs of colorectal carcinoma cells to obtain the 
amplified DNA sequences of RPL14. The DNA sample of RPL 14 was then sent to 1st Base 
Laboratory Malaysia for DNA sequencing. The RPL 14 DNA sequence was analyse using a 
few of bioinformatics tools that can be retrieved online such as BLAST (Altschul, Gish, 
Miller, Myers & Lipman, 1990) and CLUSTAL W (Thompson, Higgins & Gibson, 1994).  
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2.0 LITERATURE REVIEW 
2.1 Colorectal Carcinoma (CRC) 
Colorectal carcinoma (CRC) develops in the colon or the rectum, also known as the large 
intestine (Figure 2.1.1). According to Cappell (2005), CRC arises from mucosal colonic 











Figure 2.1.1: Human colorectal system. 
Retrieved from http://www.newhealthguide.org/Rectum-Function.html 
Histologically, hyperplastic polyps contain growing amount of glandular cells with 
decreased cytoplasmic mucus, but lack nuclear hyperchromatism. On the other hand, 
adenomatous nuclei are commonly hyperchromatic, enlarged, cigar-shaped, and crowded 
together in a palisade pattern (Tsai & Lu, 1995). Adenomas can be classified as tubular or 
villous. However in most cases, colorectal carcinoma generally originates from adenomas 
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according to screening tests, clinical, and pathologic findings (Cappell, 2005). Once 
carcinoma forms in the inner lining of the large intestine, it can grow into the wall of the 
colon or rectum. Carcinoma that has grown into the wall can also invade the blood or lymph 
vessels resulting to probable metastasizing growth of carcinoma. 
Statistically, CRC cases has increased in Malaysia from 8.1% to 12.0% in 1995 (Ministry of 
Health, 1995). Globally, CRC is the third most fatal cancer and its occurrence has been 
increasing in Asia, including Malaysia. National Cancer Registry reported 2,246 CRC cases 
has been registered nationwide, representing 12.3% of all registered cases in 2007. Cappell 
(2005) suggested that CRC is caused by a series of genetic mutations causing to 
progressively disordered local DNA replication and enhanced colonocyte replication. The 
progressive combination of multiple genetic mutations results in the evolution of normal 
mucosa to benign adenoma to carcinoma. To add, environmental factors could also be an 
important factor to the carcinoma. Reports by Mao-De and Jing (2007) proposed that 
disruption in expression level in ribosomal proteins could associate with tumour progression 
and metastasis. The idea came after RPs were isolated and screened from cDNA libraries of 
CRC. The mRNAs are seen to be overexpressed and appeared to be more abundant in CRC 
sample compared to the normal cell lines hence suggesting its role in proliferation and 








2.2 Ribosomal Proteins and RPL 14 gene 
Initially, ribosomal proteins (RPs) are recognised for their role of biosynthesizing proteins 
for any living organism. RPs, together with ribosomal RNAs (rRNAs) will join and bind 
with each other to make up the ribosome organelle in all cells. As for human ribosomes, it 
constitutes of 4 different rRNAs species and 80 distinct RPs. There are two main subunits 
of ribosomes which are the large subunit (L, 60S) and small subunit (S, 40S). Protein 
associated with ribosomes called PAR is also responsible in ribosomes synthesis and 
recycling when PAR is combined with the two ribosomal units (Mao-De & Jing, 2006). 
In 2001, 80 different RP genes were successfully mapped on the cytogenetic map of human 
genome (Mao-De & Jing, 2006). While it is agreed that most of RPs involves solely on 
protein synthesis (RPs stabilize specific rRNA structure in mature ribosomal subunits by 
supporting accurate folding of rRNAs during ribosomal assembly), attention has been 
growing to understand the probable extraribosomal functions of RPs. Extraribosomal 
function of RPs simply means that the RPs are not in any way related to help synthesize 
protein, instead, they may be involve in other functions such as DNA replication, 
transcription and repair, RNA splicing and modification, cell growth and proliferation, 
regulation of apoptosis and development, and cellular transformation. Interestingly, RP 
genes were constantly identified in of screening the differentiated expressed genes of human 
diseases especially in genetic diseases and cancers. According to Mao-De and Jing (2006), 
the disturbances RPs structures or expression levels were associated with various diseases 
such as Turner syndrome, Noonan syndrome, and Diamond-Blackfan anaemia syndrome. 
The same results was observed in several kinds of carcinoma including breasts, liver, 
oesophagus and colorectal itself. RPs can directly regulate the effect of oncogene and tumor 
suppressors on DNA replication, transcription and translation. 
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For example, overexpression of RPS3a gene has been shown to promote tumorigenesis in 
nude mice via suppression of apoptosis by inducing synthesis of anti-apoptosis proteins. 
These studies indicate that extraribosomal functions of distinct ribosomal proteins may also 
regulate tumorigenesis. 
Consequently, alterations in the synthesis or functioning of ribosomal proteins can lead to 
various hematologic disorders whereby ribosomal proteins is thought to have some genetic 
interaction with p53 gene which could explain the association between ribosomal proteins 
and cancer. Previous report had conveyed that upon receiving cellular stress, RP will bind 
to MDM2 and block MDM2-mediated p53 ubiquitination and degradation, thus resulting in 
p53- dependent cell cycle arrest (Narla & Ebert, 2010). Therefore, via this mechanism, we 
could note that ribosomal proteins plays a big part in connecting deregulated cell growth 
with inhibition of cell division. Figure shows how the Loss of ribosomal proteins activates 
p53. In a normal cell, MDM2 binds to p53 in the nucleoplasm, leading to p53 ubiquination 
and degradation. However, defective ribosome biogenesis leads free ribosomal proteins 
moving out of the nucleolus and binding MDM2, thereby preventing the degradation of p53 







Figure 2.2.1: Interaction of ribosomal proteins with p53 
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A number of studies have been conducted in investigating the pattern of various RP gene 
expression in malignant diseases. The mRNA of RPL31 cDNA was selected from a normal 
colon cDNA library and was found to be overexpressed in all 23 CRC by slot-blot 
hybridization. In situ hybridization results showed that RPL31 was more abundant in CRC 
than normal colonic epithelium or stromal tissues thus signifying its role in proliferation and 
neoplasia (Chester et al., 1989). 
The same results were shown by Pogue-Guile et al. (1991) revealing that RPS3, S6, S8, S12, 
L5, and P0 increased in CRC and adenomatous polyps except for RPL26 and RPL35. 
However, it cannot be concluded that abundance of the RPs is due to the presence of a higher 
percentage of dividing cells in tumour as the increment in CRC was not significantly 
different from the of normal colonic mucosa for every case. Nevertheless, it can still be an 
important starting indicator to understanding roles of ribosomal proteins in colon neoplasia. 
Ribosomal protein L14, or widely addressed by RPL14 gene belongs to the L14E family of 
ribosomal proteins. RPL 14 encodes for ribosomal proteins from subunit 60S. It contains a 
basic region-leucine zipper (bZIP)-like domain (Wool, Chun & Gluck, 1996). Figure 2.2.1 






Figure 2.2.2: 3D structure of RPL 14. 
Retrieved from http://proteopedia.org/wiki/index.php/Ribosomal_protein_L14 
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Besides that, Wool et al. (1996) reported that RPL 14 contains a trinucleotide (GCT) repeat 
tract whose length is highly polymorphic whereby these triplet repeats result in a stretch of 
alanine residues in the encoded protein. Transcript variants utilizing alternative polyA 
signals and alternative 5'-terminal exons exist but all encode the same protein. There are 
multiple processed pseudogenes of this gene dispersed through the genome. Human 


















2.3 Human Colorectal Cell Lines (HCT 116) 
Cancer stem cells (CSCs) are defined as the subpopulation of cells within a tumour that can 
self-renew, differentiate into multiple lineages, and drive tumour growth (Yeung et al., 
2010). This project chooses HCT 116 to study the expression of RPL 14 in human colorectal 
cell line. HCT 116 is cell line of an adult, male colon ascendens infected with colorectal 
carcinoma. Figure 2.3.1 shows the morphology of HCT 116 cells. 
 
Figure 2.3.1: HCT 116 cells morphology, scale bar 100µm.  
Taken from www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines.aspx 
HCT 116 is a highly aggressive cell line that has lost the capacity to differentiate and does 
not express CDX1 resulting in an aggressive but poorly differentiated tumour. As suggested 
by Wong et al. (2004), reduced expression of CDX1 in colorectal cancers (by methylation) 
may have possible association with reduced capacity of the CSCs to differentiate thus 
contributing to an increased growth rate of undifferentiated tumour. HCT 116 does not 
significantly separate into different types of colony-forming cells, nor does it contain other 
subpopulations of cells with higher tumour-forming capacity. This is proven in a study by 
Yeung et al. (2010) whereby HCT 116 is seen to be able to form tumours in NOD/SCID 
mice that were treated with CD44+CD24+ and CD44−CD24− cells from the HCT 116 cell 
line. The results showed that the selection does not affect the tumour forming capacity of 
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HCT116 cells, as there was no significant difference in the tumour sizes between the 
CD44+CD24+ and CD44−CD24− subpopulations. Thus, HCT 116 is inferred to contain a 
high proportion of CSCs that have lost its capability to differentiate (Choi et al., 2000).  
In summary, colorectal cancer cell lines contain subpopulations of CSCs which are 
categorized by their cell surface markers and colony morphology. They possess self-renewal 
capability and could also differentiate into multiple lineages (Ahmed et al., 2013). Figure 
2.3.2 shows colorectal carcinoma cell lines which vary in growth rate and morphology. The 
individual cell cultures are depicted by phase-contrast micrographs 24 hours after 
trypsinization and seeding. Fast-growing cancer cell lines are indicated with a yellow dot 
and slower-growing cell lines are indicated by a red dot (Ahmed et al., 2013). 
 
Figure 2.3.2: Different types of CRC cell lines, scale 100mm.  
Taken from “Epigenetic and genetic features of 24 colon cancer cell lines” by Ahmed et al., 2013, 






2.4 Sequence Analysis 
When analysing a gene sequence, normally we would start by comparing nucleic acid 
sequences. All the four nucleotides, A, T, C, and G, are found in the database with 
approximately the same frequencies and have roughly the same probability of mutating one 
into another. Therefore, as a result, DNA-DNA comparisons are largely based on 
straightforward text matching, which makes them rather slow and less sensitive. There are 
many methods to increase efficiency in analysing a sequence. One of it is by doing amino 
acid sequence comparisons as it has several distinct advantages over nucleotide sequence 
comparisons which makes it a more sensitive method of analysing DNA sequences. First, it 
is because there are 20 amino acids but only four bases, an amino acid match carries with it 
>4 bits of information as opposed to only two bits for a nucleotide match (Altschul, Gish, 
Miller, Myers & Lipman, 1990). Also, the likelihoods of amino acids substitutions occurring 
during evolution are substantially different, and thus by taking this into account greatly 
improves the sequence analysis performance. There are two basic alignment method which 
are global (full-length) and local alignment, which includes only parts of the analyzed 
sequences (subsequences) (Thompson, Higgins & Gibson, 1994). Of course global 
alignment is best to describe relationships between sequences across species but however in 
this study local alignments was used. This study utilized BLAST (Altschul, Gish, Miller, 
Myers & Lipman, 1990) and CLUSTAL W (Thompson, Higgins & Gibson, 1994) to make 







3.0 MATERIALS AND METHODS 
Table 3.0.1, 3.0.2, and 3.0.3 display the list of materials and apparatus as well as online tools 
that have been used in this study. 
Table 3.0.1: Materials and reagents 
Materials and Reagents Brand Country of Manufacturer 







DEPC-treated water Ambion® USA  
Ethidium Bromide R&M Chemicals UK 
HCT 116 Colorectal 
carcinoma cell line  
ATCC USA 
Ladder mix DNA 
(0.5µg/µl, 50 µg)  
Fermentas USA 
 Loading dye Fermentas USA 
RNase free water Promega USA 
TRIzol reagent InvitrogenTM USA 




Pfu DNA Polymerase Thermo Scientific USA 






Table 3.0.2: Tools and apparatus 
Tools and Apparatus Brand Country of Manufacturer 













Microwave Oven National Japan 
Mikro 22R Centrifuge Hettich Zentrifugen Germany 
pH meter Orion 2 Star pH Benchtop, 
Thermo Scientific 
USA 





RNA Wood Hood Köttermann Germany 
UV spectrophotometer Ultrospec 1100 pro UK 
UV transluminator Wise UV. WUV-M10 UK 
Weighing Machine Setra USA 
T100™ Thermal Cycler Bio-Rad USA 
 
Table 3.0.3: Online tools  
Online Tools Host/Inventor/Website 
NCBI primer designing 
tools 
National Centre for Biotechnology Information (NCBI)/ 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) 
Oligoanalyzer 3.1 Integrated DNA Technologies, Inc./ 
(https://sg.idtdna.com/calc/analyzer) 
Oligocalc Northwestern University/ (Kibbe, 2007)/ 
(http://www.basic.northwestern.edu/biotools/oligocalc.html) 
Basic Local Allignment 
Search Tool (BLAST) 
National Centre for Biotechnology Information (NCBI)/ 
(Altschul, Gish, Miller, Myers & LIpman, 1990)/ 
(http://blast.ncbi.nlm.nih.gov/Blast) 
CLUSTAL W The European Bioinformatics Institute (EMBL-EBI)/ 
(Thompson, Higgins & Gibson, 1994)/ 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) 
Jalview The Barton Group/ (Waterhouse, Procter, Martin, Clamp & 
Barton, 2009)/ (http://www.jalview.org/) 
Prosite Swiss Institute of Bioinformatics Biozentrum, University of 
Basel (2009)/ (http://prosite.expasy.org/) 
 
 
 
